Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Brander DM 

PROVIDER: S-EPMC12745032 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature